Website Under Maintenance

Website Under Maintenance


Our site is down for scheduled maintenance. We are working to update our network to better provide the page you requested. We understand the inconvenience this may cause, but rest assured, we are doing everything we can to bring the site back online after our necessary updates.

Feedback

Alaunos Therapeutics, Inc. - Common Stock (NQ:TCRT)

2.495 -0.005 (-0.20%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 15,668
Open 2.450
Bid (Size) 2.450 (3)
Ask (Size) 2.590 (4)
Prev. Close 2.500
Today's Range 2.450 - 2.560
52wk Range 1.314 - 6.200
Shares Outstanding 240,627,055
Dividend Yield N/A

Performance

YTD
+26.6%
+26.6%
1 Month
+18.8%
+18.8%
3 Month
-48.6%
-48.6%
6 Month
+69.7%
+69.7%
1 Year
-19.8%
-19.8%

More News

Read More

Frequently Asked Questions

Is Alaunos Therapeutics, Inc. - Common Stock publicly traded?
Yes, Alaunos Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Alaunos Therapeutics, Inc. - Common Stock trade on?
Alaunos Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alaunos Therapeutics, Inc. - Common Stock?
The ticker symbol for Alaunos Therapeutics, Inc. - Common Stock is TCRT on the Nasdaq Stock Market
What is the current price of Alaunos Therapeutics, Inc. - Common Stock?
The current price of Alaunos Therapeutics, Inc. - Common Stock is 2.495
When was Alaunos Therapeutics, Inc. - Common Stock last traded?
The last trade of Alaunos Therapeutics, Inc. - Common Stock was at 09/26/25 03:59 PM ET
What is the market capitalization of Alaunos Therapeutics, Inc. - Common Stock?
The market capitalization of Alaunos Therapeutics, Inc. - Common Stock is 600.36M
How many shares of Alaunos Therapeutics, Inc. - Common Stock are outstanding?
Alaunos Therapeutics, Inc. - Common Stock has 600M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.